设为首页| 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 联系我们 下载专区
最新消息:
位置:首页 >> 期刊文章
344例原发性肝癌临床分析
作者:李芳芳 刘剑波 
单位:郴州市第一人民医院中心医院 消化科 郴州市 423000 
关键词:肝炎 乙型 肝肿瘤 疾病特征 乙肝疫苗 
分类号:
出版年,卷(期):页码:2010,2(3):15-17
摘要:

目的 研究原发性肝癌(primary  liver cancer,PLC)临床特征及病因,探讨可能阻断肝癌发展的因素。方法 回顾分析本院2007年1月至2009年12月PLC患者的临床资料,结合以往的临床研究,讨论PLC的病因、治疗及预防。结果 PLC患者确诊时多为中晚期,肝内转移者达88.95%,门脉及下腔静脉血栓形成者达40.69%,能通过肝癌切除手术者仅为21.80%,有90.69%系慢性乙型肝炎患者或既往感染者,83.43%患者有肝硬化基础,乙型肝炎病毒HBsAg、抗-HBe、抗-HBc阳性是主要感染模式,占64.53%。结论 PLC多发生在慢性肝病基础上且预后差,手术切除是最佳的治疗方案。对于肝脏储备功能差且不能切除的肝癌患者,肝移植是有效的治疗方案。乙型肝炎病毒感染是PLC发病的主要病因,主要感染模式是乙型肝炎病毒HBsAg、抗-HBe、抗-HBc阳性,乙肝疫苗能有效降低感染率,从而预防肝癌的发生。

Objective To analyze  the clinical  feature and etiological  factors of primary  liver cancer  (PLC) and explore effective methods  to prevent PLC. Methods Total of 344 PLC cases  from  January 2007  to December 2009 were analyzed retrospectively. Combined with previous clinical research, etiology, treatment and prevention of PLC were discussed. Results Most of PLC patients were  in  intermediate or  late stage when they were diagnosed. Among the patients, 88.95% (306/344) occured liver transfer, 40.69% (140/344) occured portal vein and  inferior vena  tumor  thrombus, only 21.80% patients were suit  for operation. And 83.43% (287/344) patients had hepatic cirrhosis,  the major  infection mode was   HBsAg, anti-HBe and anti-HBc positive which  represents approximately 64.53%. Conclusions Primary  liver  tumor usually occurs  in the setting of chronic  liver disease with poor prognosis. Operation  is  rather  ideal  for  liver cancer. With  the development of medicine, liver transplantation is the definitive therapy for early, unresectable PLC with poor liver  function. Hepatitis B virus  infection  is an  important etiology  for hepatocellular carcinoma. The main infective pattern of HBV HBsAg, anti-HBe and anti-HBc positive. Vaccination is most effective in reducing the incidence of HBV infection and PLC preventation.

基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 

地址:北京市朝阳区京顺东街8号
邮政编码:100015  电话:010-84322058  传真:010-84322059 Email:editordt@163.com